Is the Alere Dispute Hurting Abbott’s Strategic Position?

As the battle over the $5.8 billion Alere merger enters a new and nastier stage, there are indications that the conflict may be harming Abbott's strategic standing and ability to do other M&A … [Read more...]


2017 Clinical Laboratory Fee Schedule: The 3 Changes Affecting Your Reimbursement

The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. The winners: The small group of labs that provide new specialty molecular … [Read more...]


FDA Puts LDT Guidance on Ice

Whether you dreaded it or craved it, final guidance from the U.S. Food and Drug Administration (FDA) on laboratory-developed tests (LDT) will not be issued in December. The FDA confirmed that it will … [Read more...]


So, Now What? How a Trump Presidency Will Impact Labs & the ACA

Needless to say, the election of Donald Trump will have major ramifications on not just labs but the entire health care industry. But while changes are a certainty, it is far from clear what and how … [Read more...]


Crosswalked Codes in 2017 Clinical Laboratory Fee Schedule

CPT Code Crosswalked To 80305 (Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical … [Read more...]


3 Things We Learned from New OIG Report on 2015’s Top 25 Lab Tests by Medicare Payment

Buried in the back of the Office of Inspector General (OIG) recent report on 2015 Medicare payments for Part B lab tests are three key revelations about the new Protecting Access to Medicare Act of … [Read more...]


PAMA Update: OIG Status Report on Implementing New Medicare Fee Schedule for Part B Lab Tests

Transition to the new Medicare Part B payment system for lab tests under the Protecting Access to Medicare Act of 2014 (PAMA) is in full swing and about to heat up. With D-day set for Jan. 1, 2018, … [Read more...]


Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry

Ex-Hospital Exec Pays $1 Million for Role in Kickback Scheme. Case: Last fall, Tuomey Healthcare shelled out $72.4 million to settle claims of paying part-time specialists for referrals of hospital … [Read more...]


News at a Glance – September 2016

HIMSS Says Hospitals Slow to Adopt Precision Medicine. Precision medicine is slowly taking hold at the nation's hospitals, but the need to build up information technology to make it an organic part of … [Read more...]


News at a Glance – July 2016

Gapfill Prices Cut Reimbursement for Molecular Testing. The Centers for Medicare & Medicaid Services (CMS) published interim gapfill prices for new CPT codes for molecular tests introduced earlier … [Read more...]